Literature DB >> 12050099

Effects of perillyl alcohol on melanoma in the TPras mouse model.

Maria Lluria-Prevatt1, Jeanne Morreale, Jacie Gregus, David S Alberts, Fiona Kaper, Amato Giaccia, Marianne Broome Powell.   

Abstract

This study evaluates the chemopreventive effects of topically applied perillyl alcohol on the development of melanoma in TPras transgenic mice. Our strategy was to target critical pathways in the development of melanoma, in particular, the ras pathway. Ras has been shown in our experimental mouse model, as well as others, to be important in the development and maintenance of melanomas. Perillyl alcohol (POH), a naturally occurring monoterpene, inhibits the isoprenylation of small G protein, including Ras. POH (10 mM) was applied to the shaved dorsal skin of TPras mice starting 1 week before five treatments of dimethylbenz[a]anthracene (50 microg) and was continued for 38 weeks. We observed a delay in the appearance of tumors and a 25-35% reduction in melanoma incidence. POH treatment of melanoma cells in vitro reduced the levels of detectable Ras protein and inhibits the activation of downstream targets, mitogen-activated protein kinases and Akt. POH only minimally induced apoptosis in this system. Pretreatment but not post-treatment of the melanoma cells with POH, however, markedly reduced levels of UV-induced reactive oxygen species. These studies suggest that POH inhibition of the Ras signaling pathway may be an effective target for chemoprevention of melanoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050099

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

Review 1.  Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  Botanicals for the prevention and treatment of cutaneous melanoma.

Authors:  Deeba N Syed; Hasan Mukhtar
Journal:  Pigment Cell Melanoma Res       Date:  2011-04-12       Impact factor: 4.693

Review 3.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

4.  Preformulation, formulation, and in vivo efficacy of topically applied apomine.

Authors:  Philip J Kuehl; Steven P Stratton; Marianne B Powell; Paul B Myrdal
Journal:  Int J Pharm       Date:  2009-08-20       Impact factor: 5.875

Review 5.  Chemoprevention of melanoma.

Authors:  Subbarao V Madhunapantula; Gavin P Robertson
Journal:  Adv Pharmacol       Date:  2012

6.  A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer.

Authors:  Steven P Stratton; David S Alberts; Janine G Einspahr; Paul M Sagerman; James A Warneke; Clara Curiel-Lewandrowski; Paul B Myrdal; Kelly L Karlage; Brian J Nickoloff; Chris Brooks; Kathylynn Saboda; Michael L Yozwiak; Mary F Krutzsch; Chengcheng Hu; Maria Lluria-Prevatt; Zigang Dong; G Timothy Bowden; Peter H Bartels
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-26

Review 7.  Discovery of new anticancer agents from higher plants.

Authors:  Li Pan; Hee-Byung Chai; Alan Douglas Kinghorn
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

Review 8.  Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma.

Authors:  Marta Di Martile; Stefania Garzoli; Rino Ragno; Donatella Del Bufalo
Journal:  Cancers (Basel)       Date:  2020-09-16       Impact factor: 6.639

Review 9.  Essential Oils as Multicomponent Mixtures and Their Potential for Human Health and Well-Being.

Authors:  Marek Bunse; Rolf Daniels; Carsten Gründemann; Jörg Heilmann; Dietmar R Kammerer; Michael Keusgen; Ulrike Lindequist; Matthias F Melzig; Gertrud E Morlock; Hartwig Schulz; Ralf Schweiggert; Meinhard Simon; Florian C Stintzing; Michael Wink
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

Review 10.  The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.

Authors:  Thomas C Chen; Clovis O da Fonseca; Daniel Levin; Axel H Schönthal
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.